Showing results (121-130 of 317) with videos related to
Sort By:
Pageof 32
European Journal of Cancer (Oxford, England : 1990)|July 16, 2023
Faecal microbiota composition is related to response to CDK4/6-inhibitors in metastatic breast cancer: A prospective cross-sectional exploratory studyFrancesco Schettini, Alessandra Fontana, Federica Gattazzo, et al.Journal of the National Cancer Institute. Monographs|June 12, 2015
Neoadjuvant Model in Cancer Treatment: From Clinical Opportunity to Health-Care UtilityDaniele Generali, Stephen B Fox, Massimo Cristofanilli, et al.Cancers|January 11, 2024
Oral Problems in Oncology Patients Undergoing Chemotherapy for Solid Tumors: A Prospective Observational StudyGiulia Ottaviani, Giada Targato, Katia Rupel, et al.Cancer Chemotherapy and Pharmacology|December 2, 2025
Impact of adverse events on survival outcomes in patients treated with CDK4/6 inhibitors for advanced breast cancerMartina Catalano, Gestiana Cekrezi, Irene De Gennaro Aquino, et al.Breast (Edinburgh, Scotland)|June 3, 2026
A mixed prebiotic/probiotic intervention (MBR-01) for the management of diarrhea during abemaciclib treatment of early breast cancer in postmenopausal patients: A single-center prospective case-control pilot studyDaniele Generali, Alexandro Membrino, Alessandra Fontana, et al.Cancers|September 9, 2023
Epithelioid Mesothelioma Patients with Very Long Survival Display Defects in DNA RepairMonica Ganzinelli, Federica Guffanti, Anna Ianza, et al.Breast Cancer Research and Treatment|August 22, 2013
Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signalingClaudia Fumarola, Cristina Caffarra, Silvia La Monica, et al.Expert Review of Anticancer Therapy|November 27, 2020
Trastuzumab emtansine (T-DM1) as adjuvant treatment of HER2-positive early breast cancer: safety and efficacyChiara Molinelli, Francesca Parisi, Maria Grazia Razeti, et al.Journal of the National Cancer Institute. Monographs|November 2, 2011
Molecular oncology and the neoadjuvant setting: the perfect blend for treatment personalization and clinical trial designDaniele Generali, Alfredo Berruti, Chiara Foroni, et al.Oncotarget|November 24, 2015
Taxanes enhance trastuzumab-mediated ADCC on tumor cells through NKG2D-mediated NK cell recognitionMartina Di Modica, Lucia Sfondrini, Viola Regondi, et al.Pageof 32